NanoString Technologies Inc.

NanoString Technologies Inc is an American biotechnology company that specialises in the development of life science tools to facilitate the early diagnosis of disease. The company's technology enables a wide variety of research, translational medicine and in vitro diagnostics applications. Founded in 2003, the firm is based in Seattle, Washington, and serves an audience of customers within the global healthcare services industry, through partnerships and collaborations with global distributors across more than 40 countries. The firm launched as a public company in 2013 and trades on the NASDAQ GM where it is listed under the ticker NSTG. In December 2020 the NSTG price chart showed a 52 week high of $72.50 and a 52 week low of $13.85, with a market cap of $3.04bn. In 2019, the company launched the GeoMx™ Digital Spatial Profiler which facilitates spatial profiling of RNA and protein targets in a variety of sample types. The company’s nCounter® Analysis System is now being used in cancer research, biomarker validation and screening and next generation sequencing validation. Are you looking to diversify your portfolio on eToro? Add this instrument to your watchlist and keep up to date with all the latest news and updates on the NSGT price chart.